NL
NL · NL · NL-5fbc50a832b1
Lytenava 25 mg/ml oplossing voor injectie
ATC S01LA08
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerOutlook Therapeutics NL B.V.
CountryNL (NL)
ATC codeS01LA08
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/24/1798
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Oplossing voor injectie",
"route": "Intravitreaal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/lytenava-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Bevacizumab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130861",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"POLYSORBAAT 20 (E 432)",
"STIKSTOF (HEAD SPACE) (E 941)",
"TREHALOSE (Alpha, Alpha-) 2-WATER",
"WATER VOOR INJECTIE"
],
"substances": [
"BEVACIZUMAB GAMMA"
],
"leaflet_url": null,
"authorised_at": "2024/05/27",
"procedure_number": "EMEA/H/C/005723",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/24/1798",
"additional_monitoring": "Y"
}Related drugs
Other records sharing ATC code S01LA08.
- DKLytenavaOutlook Therapeutics NL B.V.
- PLLytenavaOutlook Therapeutics Limited
- ISLytenavaOutlook Therapeutics NL B.V.
- FILytenavaOutlook Therapeutics NL B.V.
- CZLYTENAVAOutlook Therapeutics NL B.V., Amsterdam
- BELytenava 25 mg/mlOutlook Therapeutics NL
- IELytenava 25 mg/mL solution for injectionOutlook Therapeutics NL B.V.
Access this data programmatically
Query Lytenava 25 mg/ml oplossing voor injectie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.